World Journal of Surgery

, Volume 42, Issue 8, pp 2570–2578 | Cite as

Indocyanine Green Retention Rates at 15 min Predicted Hepatic Decompensation in a Western Population

  • Bertrand Le RoyEmail author
  • Emilie Grégoire
  • Cyril Cossé
  • Badr Serji
  • Nicolas Golse
  • René Adam
  • Daniel Cherqui
  • Jean-Yves Mabrut
  • Yves-Patrice Le Treut
  • Eric Vibert
Original Scientific Report



ICGR15 is widely used in Asia to evaluate the liver reserve before hepatectomy, but not in Western countries where patients are selected using the MELD score and/or platelet count. Postoperative liver failure is rare nowadays, but hepatic decompensation (HD), defined by 3-month postoperative ascites, impairs quality of life and survival. The aim of this study was to evaluate the relevance of indocyanine green retention rate at 15 min (ICGR15) before liver resection in Western countries, in order to predict HD.


This prospectively designed study included consecutive adult patients undergoing hepatectomy for hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC) in three French HPB centres.


Between 2012 and 2014, 147 patients were included (80% of HCC and 20% of ICC). The Child–Pugh status was grade A for all patients. In the overall population and in F3/F4 patients (n = 83), ICGR15 (P = 0.02) and platelet counts (P = 0.02) were predictive of HD under multivariate analysis. Among F3/F4 patients undergoing minor hepatectomy with preoperative ICGR15 > 15%, the rate of HD was 36%. In the overall population, ICGR15 was predictive of HD (P = 0.02) and postoperative ascites (P = 0.03). The ROC curve identified a cut-off point of 15% as being associated with increased HD, with good accuracy for ICGR15 in the study population (AUROC 0.73), mainly before minor hepatectomy (AUROC 0.79).


In patients with HCC and ICC selected using the MELD score and platelet rate, an ICGR15 > 15% is a relevant, non-invasive and clearly accurate method to predict HD specially before minor hepatectomy.


Compliance with ethical standards

Conflict of interest and source of funding

All authors declare that they have no conflicts of interest or sources of funding concerning this article.

Supplementary material

268_2018_4464_MOESM1_ESM.doc (32 kb)
Supplementary material 1 (DOC 31 kb)


  1. 1.
    Rahbari NN, Garden OJ, Padbury R et al (2011) Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery 149:713–724CrossRefPubMedGoogle Scholar
  2. 2.
    Schreckenbach T, Liese J, Bechstein WO et al (2012) Posthepatectomy liver failure. Dig Surg 29:79–85CrossRefPubMedGoogle Scholar
  3. 3.
    Bruix J, Castells A, Bosch J et al (1996) Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure. Gastroenterology 111:1018–1022CrossRefPubMedGoogle Scholar
  4. 4.
    Balzan S, Belghiti J, Farges O et al (2005) The “50–50 criteria” on postoperative day 5: an accurate predictor of liver failure and death after hepatectomy. Ann Surg 242:824–828 (discussion 828–29) CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Mullen JT, Ribero D, Reddy SK et al (2007) Hepatic insufficiency and mortality in 1059 noncirrhotic patients undergoing major hepatectomy. J Am Coll Surg 204:854–862 (discussion 862–64) CrossRefPubMedGoogle Scholar
  6. 6.
    Torzilli G, Belghiti J, Kokudo N et al (2013) A snapshot of the effective indications and results of surgery for hepatocellular carcinoma in tertiary referral centers: is it adherent to the EASL/AASLD recommendations? An observational study of the HCC East-West study group. Ann Surg 257:929–937CrossRefPubMedGoogle Scholar
  7. 7.
    Fan ST, Lo CM, Liu CL et al (1999) Hepatectomy for hepatocellular carcinoma: toward zero hospital deaths. Ann Surg 229:322–330CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Douard R, Lentschener C, Ozier Y et al (2009) Operative risks of digestive surgery in cirrhotic patients. Gastroentérol Clin Biol 33:555–564CrossRefPubMedGoogle Scholar
  9. 9.
    Nanashima A, Tobinaga S, Abo T et al (2010) Reducing the incidence of post-hepatectomy hepatic complications by preoperatively applying parameters predictive of liver function. J Hepato Biliary Pancreat Sci 17:871–878CrossRefGoogle Scholar
  10. 10.
    Lee LJ-H, Chen C-H, Yao G et al (2007) Quality of life in patients with hepatocellular carcinoma received surgical resection. J Surg Oncol 95:34–39CrossRefPubMedGoogle Scholar
  11. 11.
    Imamura H, Sano K, Sugawara Y et al (2005) Assessment of hepatic reserve for indication of hepatic resection: decision tree incorporating indocyanine green test. J Hepatobiliary Pancreat Surg 12:16–22CrossRefPubMedGoogle Scholar
  12. 12.
    Cucchetti A, Ercolani G, Vivarelli M et al (2006) Impact of model for end-stage liver disease (MELD) score on prognosis after hepatectomy for hepatocellular carcinoma on cirrhosis. Liver Transpl 12:966–971CrossRefPubMedGoogle Scholar
  13. 13.
    Bruix J, Sherman M, Practice Guidelines Committee, American Association for the Study of Liver Diseases (2005) Management of hepatocellular carcinoma. Hepatol Baltim Md 42:1208–1236CrossRefGoogle Scholar
  14. 14.
    Cucchetti A, Ercolani G, Vivarelli M et al (2009) Is portal hypertension a contraindication to hepatic resection? Ann Surg 250:922–928CrossRefPubMedGoogle Scholar
  15. 15.
    Makuuchi M, Kosuge T, Takayama T et al (1993) Surgery for small liver cancers. Semin Surg Oncol 9(4):298–304CrossRefPubMedGoogle Scholar
  16. 16.
    Nonami T, Nakao A, Kurokawa T et al (1999) Blood loss and ICG clearance as best prognostic markers of post-hepatectomy liver failure. Hepatogastroenterology 46:1669–1672PubMedGoogle Scholar
  17. 17.
    Lisotti A, Azzaroli F, Buonfiglioli F et al (2014) Indocyanine green retention test as a noninvasive marker of portal hypertension and esophageal varices in compensated liver cirrhosis. Hepatology 59:643–650CrossRefPubMedGoogle Scholar
  18. 18.
    Ohwada S, Kawate S, Hamada K et al (2006) Perioperative real-time monitoring of indocyanine green clearance by pulse spectrophotometry predicts remnant liver functional reserve in resection of hepatocellular carcinoma. Br J Surg 93:339–346CrossRefPubMedGoogle Scholar
  19. 19.
    Uesaka K, Nimura Y, Nagino M (1996) Changes in hepatic lobar function after right portal vein embolization. An appraisal by biliary indocyanine green excretion. Ann Surg 223:77–83CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Dindo D, Demartines N, Clavien P-A (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Pugh RN, Murray-Lyon IM, Dawson JL et al (1973) Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 60:646–649CrossRefPubMedGoogle Scholar
  22. 22.
    Kamath PS, Wiesner RH, Malinchoc M et al (2001) A model to predict survival in patients with end-stage liver disease. Hepatology 33:464–470CrossRefPubMedGoogle Scholar
  23. 23.
    Lau H, Man K, Fan ST et al (1997) Evaluation of preoperative hepatic function in patients with hepatocellular carcinoma undergoing hepatectomy. Br J Surg 84:1255–1259CrossRefPubMedGoogle Scholar
  24. 24.
    Capussotti L, Ferrero A, Viganò L et al (2006) Portal hypertension: Contraindication to liver surgery? World J Surg 30:992–999. doi: CrossRefPubMedGoogle Scholar
  25. 25.
    Torzilli G, Makuuchi M, Inoue K et al (1999) No-mortality liver resection for hepatocellular carcinoma in cirrhotic and noncirrhotic patients: is there a way? A prospective analysis of our approach. Arch Surg 134:984–992CrossRefPubMedGoogle Scholar
  26. 26.
    Umeda Y, Yagi T, Sadamori H et al (2008) Effects of prophylactic splenic artery modulation on portal overperfusion and liver regeneration in small-for-size graft. Transplantation 86:673–680CrossRefPubMedGoogle Scholar
  27. 27.
    Ishizawa T, Hasegawa K, Aoki T et al (2008) Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma. Gastroenterology 134(7):1908–1916CrossRefPubMedGoogle Scholar
  28. 28.
    Yamazaki S, Takayama T, Nakamura M et al (2014) Prophylactic impact of endoscopic treatment for esophageal varices in liver resection: a prospective study. J Gastroenterol 49:917–922CrossRefPubMedGoogle Scholar
  29. 29.
    Silva-Junior G, Baiges A, Turon F et al (2015) The prognostic value of hepatic venous pressure gradient in patients with cirrhosis is highly dependent on the accuracy of the technique. Hepatol Baltim Md 62:1584–1592CrossRefGoogle Scholar
  30. 30.
    Steinlauf AF, Garcia-Tsao G, Zakko MF et al (1999) Low-dose midazolam sedation: an option for patients undergoing serial hepatic venous pressure measurements. Hepatology 29:1070–1073CrossRefPubMedGoogle Scholar
  31. 31.
    Reverter E, Blasi A, Abraldes JG et al (2014) Impact of deep sedation on the accuracy of hepatic and portal venous pressure measurements in patients with cirrhosis. Liver Int 34:16–25CrossRefPubMedGoogle Scholar

Copyright information

© Société Internationale de Chirurgie 2018

Authors and Affiliations

  • Bertrand Le Roy
    • 1
    • 4
    Email author
  • Emilie Grégoire
    • 2
  • Cyril Cossé
    • 1
  • Badr Serji
    • 1
  • Nicolas Golse
    • 1
    • 3
  • René Adam
    • 1
  • Daniel Cherqui
    • 1
  • Jean-Yves Mabrut
    • 3
  • Yves-Patrice Le Treut
    • 2
  • Eric Vibert
    • 1
  1. 1.Centre Hépato-biliaireHôpital Paul BrousseVillejuifFrance
  2. 2.Department of Hepatobiliary SurgeryHôpital de la ConceptionMarseilleFrance
  3. 3.Department of Hepatobiliary SurgeryHôpital La Croix-RousseLyonFrance
  4. 4.Department of Hepatobiliary SurgeryHôpital EstaingClermont FerrandFrance

Personalised recommendations